Two decades of high dose rate brachytherapy with external beam radiotherapy for prostate cancer.
CONCLUSION: The combination of EBRT and HDR-BT with adequate dose constraints to risk organs provides satisfactory long-term tumour control even in high-risk patients. GI toxicity stabilised but GU toxicity progressed during the 10-year follow up.
PMID: 29496280 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Åström L, Grusell E, Sandin F, Turesson I, Holmberg L Tags: Radiother Oncol Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | External Beam Therapy | Prostate Cancer | Radiology | Study | Toxicology